SYNERGY
Avatar

Comparison of DEB with Conventional TACE in the Management of HCC

By SYNERGY FEATURING Daniel Brown
By SYNERGY FEATURING Daniel Brown
911 views
March 25, 2015
Synergy 2015 - November 5-8, 2015 http://synergymiami.org/
Comments 0
Login to view comments. Click here to Login

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Related Videos

Yale Cancer Center

Colorectal Cancer Webinar

Thu, Mar 27, 2025
See 1 other
Total Health

Cancer Updates GI and Lung

Thu, Mar 13, 2025
See 1 other
32:47

Multidisciplinary Approach to Hepatocellular Carcinoma

UCLA Health

G. Choi, B. Yanny, S. Sadeghi, J. Hui

476 views
08:04

Early HCC: Surveillance and Diagnosis

The France Foundation

V. Ajmera

101 views
30:49

Updates in Hepatocellular Carcinoma

Michigan Medicine

N. Razumilava

192 views
13:05

ESMO 2024 Summary: Highlights in HCC

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

289 views
07:01

Resection, Ablation, and the Emerging Role of Immunotherapy in Early…

The France Foundation

A. Burgoyne

90 views
20:26

Choosing the Best HCC Treatment Based on Patient and Disease Stage

Integrity CE

M. Pishvaian, R. Finn, R. Salem, A. Singal

218 views
25:31

Management of Hepatocellular Carcinoma

8th Annual Liver Conference

A. Singal

161 views
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views
14:28

ESMO 2024 Summary: Updates in HCC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

H. Babiker

224 views
07:53

Treatment Approaches in Early-Stage HCC: An Overview of Curative Tre…

The France Foundation

A. Burgoyne

74 views
07:41

Impact of Neoadjuvant IO on Recurrence-Free Survival in High-Risk Lo…

Johns Hopkins

M. Nakazawa

146 views
15:58

New

ASCO® GI 2025 Summary: Intermediate HCC and the Management of Liver …

Insights from 2025 ASCO® GI Annual Meeting

M. Reig

51 views
19:15

New

ASCO® GI 2025 Summary: Key Trial Highlights in Hepatobiliary Cancer …

Insights from 2025 ASCO® GI Annual Meeting

R. Kim, T. Biachi

66 views
25:09

ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC"

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

412 views
15:05

Expert Panel on Sequencing Treatments in HCC

Integrity CE

M. Pishvaian, R. Finn, A. Singal, R. Salem

92 views
08:09

ESMO 2024 Summary: Optimizing Curative Opportunities in Early HCC

2024 ESMO Annual Meeting Insights Hub

S. L. Chan

115 views
21:11

Hepatocellular Carcinoma: Current Management Strategies

Stanford Medicine

R. Dhanasekaran

251 views
57:44

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

5.4K views
15:53

Understanding HCC: Perspectives on Diagnosis, Risk Factors, and Trea…

Yale Cancer Center

A. Jaffe

344 views
05:40

New

Liver Transplant and the Emerging Role of Immunotherapy in Early-Sta…

The France Foundation

V. Ajmera

12 views
AUTOPLAY